Author:
Arulkumaran Nishkantha,Snow Timothy A.C.,Kulkarni Adarsh,Brealey David,Rickman Hannah M.,Rees-Spear Chloe,Spyer Moira J.,Heaney Judith,Garr Edmund,Williams Bryan,Cherepanov Peter,Kassiotis George,Lunn Michael P.,Ambler Gareth,Houlihan Catherine,McCoy Laura E.,Nastouli Eleni,Singer Mervyn
Funder
Defence Science and Technology Laboratory
Roche
NIHR Bristol Biomedical Research Centre
Baxter International
Medical Research Council
Shionogi
Bayer
UCLH Biomedical Research Centre
Allos Therapeutics
NIHR UCLH BRC
Subject
Critical Care and Intensive Care Medicine
Reference6 articles.
1. Characterization of the inflammatory response to severe COVID-19 illness;McElvaney;Am J Respir Crit Care Med,2020
2. Immunomodulators in COVID-19: two sides to every coin;Snow;Am J Respir Crit Care Med,2020
3. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial;Lancet.,2021
4. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial;Veiga;BMJ,2021
5. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials;Snow;Intensive Care Med,2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献